Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics.

Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...

Fueled by a unique blend of innovation, talent, and collaboration, Austin has built a reputation as a tech powerhouse, but ...

Amy Webb: Living intelligence is an emerging very, very early days, emerging area of science and technology that describes the interplay between artificial intelligence and sensor technology and ...

Recent developments in health highlight key agreements between countries, drug approvals, corporate revenue growth, and ...

Protein Engineering Market IntroductionThe protein engineering market is rapidly evolving, driven by the need to develop proteins with improved functionality for a range of applications, including ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Nautilus Biotechnology, Inc. ( NASDAQ: NAUT) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Executive Officer Parag ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

WALTHAM, MASSACHUSETTS / ACCESS Newswire / April 28, 2025 / Data4Cure, Inc., a leading biomedical data-to-knowledge company, today announced the presentation of two new research abstracts at the 2025 ...

Microbial biotechnology has emerged as a promising area in the production of food coloring, flavoring, and fragrance, driven by the pressing need for ...